Vysioneer
Cambridge, US · Founded 2019 · Delaware corporation · 1 known investors
Vysioneer is an oncology AI company that builds an FDA-cleared, cloud-based machine learning platform providing lesion-level tumor analysis to measure drug efficacy. Its tools serve pharmaceutical companies and clinicians to match cancer patients with appropriate treatments.
Founders & leadership
YY
Yu-Shan YangExecutive Officer, Director
JL
Jen-Tang LuExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$750KraisedJun 2023 · 1 investors · Other TechnologyRule 506(b)
▶$750KraisedJun 2023 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Luke ArmourDirector
- Amount sold
- $750K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedJan 2021 · 5 investors · Other TechnologyRule 506(b)
▶$1.5MraisedJan 2021 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $1
- First sale
- Dec 2020
- Incorporated
- Corporation, Massachusetts, 2019
- Federal exemptions
- 06b
▶$500KraisedSep 2019 · 6 investors · Other TechnologyRule 506(b)
▶$500KraisedSep 2019 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Amount sold
- $500K
- Minimum investment
- $1
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.